Article
Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of…
Neuropsychiatric Disease and Treatment · 2019 · Citrome L, Du Y, Weiden PJ
Key facts
| Title | Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm |
|---|---|
| First author | Citrome L, Du Y, Weiden PJ |
| Journal | Neuropsychiatric Disease and Treatment |
| Published | Sep 12, 2019 |
| DOI | 10.2147/NDT.S207910 |
| Devices mentioned | K791153 |
| Product codes mentioned | JAK |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1